These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26427560)

  • 1. Influence of remission and its duration on development of early microvascular complications in young adults with type 1 diabetes.
    Niedzwiecki P; Pilacinski S; Uruska A; Adamska A; Naskret D; Zozulinska-Ziolkiewicz D
    J Diabetes Complications; 2015; 29(8):1105-11. PubMed ID: 26427560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of future microvascular and macrovascular disease in people with Type 1 diabetes of very long duration: a national study with 10-year follow-up.
    Adamsson Eryd S; Svensson AM; Franzén S; Eliasson B; Nilsson PM; Gudbjörnsdottir S
    Diabet Med; 2017 Mar; 34(3):411-418. PubMed ID: 27647178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Teenage girls with type 1 diabetes have poorer metabolic control than boys and face more complications in early adulthood.
    Samuelsson U; Anderzén J; Gudbjörnsdottir S; Steineck I; Åkesson K; Hanberger L
    J Diabetes Complications; 2016 Jul; 30(5):917-22. PubMed ID: 27052153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidences of Severe Hypoglycemia and Diabetic Ketoacidosis and Prevalence of Microvascular Complications Stratified by Age and Glycemic Control in U.S. Adult Patients With Type 1 Diabetes: A Real-World Study.
    Pettus JH; Zhou FL; Shepherd L; Preblick R; Hunt PR; Paranjape S; Miller KM; Edelman SV
    Diabetes Care; 2019 Dec; 42(12):2220-2227. PubMed ID: 31548241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes in youth beyond the first year of type 1 diabetes: Results of the Pediatric Diabetes Consortium (PDC) type 1 diabetes new onset (NeOn) study.
    Cengiz E; Cheng P; Ruedy KJ; Kollman C; Tamborlane WV; Klingensmith GJ; Gal RL; Silverstein J; Lee J; Redondo MJ; Beck RW;
    Pediatr Diabetes; 2017 Nov; 18(7):566-573. PubMed ID: 27758023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of and risk factors for hospitalisations due to vascular complications: A population-based type 1 diabetes cohort (n=1316) followed into early adulthood.
    Cooper MN; de Bock MI; Carter KW; de Klerk NH; Jones TW; Davis EA
    J Diabetes Complications; 2017 May; 31(5):843-849. PubMed ID: 28242271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The remission phase in adolescents and young adults with newly diagnosed type 1 diabetes mellitus: prevalence, predicting factors and glycemic control during follow-up.
    Yazidi M; Mahjoubi S; Oueslati I; Chaker F; Chihaoui M
    Arch Endocrinol Metab; 2022 Apr; 66(2):222-228. PubMed ID: 35315990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher risk of microvascular complications in smokers with type 1 diabetes despite intensive insulin therapy.
    Uruska A; Araszkiewicz A; Uruski P; Zozulinska-Ziolkiewicz D
    Microvasc Res; 2014 Mar; 92():79-84. PubMed ID: 24423616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking and other factors associated with short-term partial remission of Type 1 diabetes in adults.
    Pilacinski S; Adler AI; Zozulinska-Ziolkiewicz DA; Gawrecki A; Wierusz-Wysocka B
    Diabet Med; 2012 Apr; 29(4):464-9. PubMed ID: 21978224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small fibre dysfunction, microvascular complications and glycaemic control in type 1 diabetes: a case-control study.
    Vas PR; Green AQ; Rayman G
    Diabetologia; 2012 Mar; 55(3):795-800. PubMed ID: 22193513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic outcomes in young children with type 1 diabetes differ between treatment centers: the Hvidoere Study in Young Children 2009.
    de Beaufort CE; Lange K; Swift PG; Aman J; Cameron F; Castano L; Dorchy H; Fisher LK; Hoey H; Kaprio E; Kocova M; Neu A; Njolstad PR; Phillip M; Schoenle E; Robert JJ; Urukami T; Vanelli M; Danne T; Barrett T; Chiarelli F; Aanstoot HJ; Mortensen HB;
    Pediatr Diabetes; 2013 Sep; 14(6):422-8. PubMed ID: 22957743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Earlier intensified insulin treatment of Type 1 diabetes and its association with long-term macrovascular and renal complications.
    Rathsman B; Donner M; Ursing C; Nyström T
    Diabet Med; 2016 Apr; 33(4):463-70. PubMed ID: 26315152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micro- and macrovascular outcomes in Type 2 diabetic patients treated with insulin glulisine or human regular insulin: a retrospective database analysis.
    Kress S; Kostev K; Dippel FW; Giani G; Rathmann W
    Int J Clin Pharmacol Ther; 2012 Nov; 50(11):821-9. PubMed ID: 22578200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-varying risk of microvascular complications in latent autoimmune diabetes of adulthood compared with type 2 diabetes in adults: a post-hoc analysis of the UK Prospective Diabetes Study 30-year follow-up data (UKPDS 86).
    Maddaloni E; Coleman RL; Agbaje O; Buzzetti R; Holman RR
    Lancet Diabetes Endocrinol; 2020 Mar; 8(3):206-215. PubMed ID: 32032540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced morbidity at diagnosis and improved glycemic control in children previously enrolled in DiPiS follow-up.
    Lundgren M; Sahlin Å; Svensson C; Carlsson A; Cedervall E; Jönsson B; Jönsson I; Larsson K; Lernmark Å; Neiderud J; Vigård T; Elding Larsson H;
    Pediatr Diabetes; 2014 Nov; 15(7):494-501. PubMed ID: 24823816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for necrobiosis lipoidica in Type 1 diabetes mellitus.
    Hammer E; Lilienthal E; Hofer SE; Schulz S; Bollow E; Holl RW;
    Diabet Med; 2017 Jan; 34(1):86-92. PubMed ID: 27101431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A 20-year prospective follow-up study to evaluate the development of retinopathy and nephropathy after the onset of type 1 diabetes mellitus: Contribution of glycemic control and metabolic memory].
    Bolotskaya LL; Bessmertnaya EG; Shestakova MV; Shamkhalova MS; Nikankina LV; Ilyin AV; Glek IS; Zolotukhin AV; Dedov II
    Ter Arkh; 2017; 89(10):17-21. PubMed ID: 29171465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower air ozone concentration is associated with clinical remission in type 1 diabetes diagnosed in adulthood: a prospective, observational study in Wielkopolska region, Poland.
    Ciepłucha W; Cieluch A; Jaz K; Flotyńska J; Nowicka A; Ciepłucha A; Zozulińska-Ziółkiewicz D; Uruska A
    Pol Arch Intern Med; 2024 Jan; 134(1):. PubMed ID: 38164523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced progression of diabetic microvascular complications with islet cell transplantation compared with intensive medical therapy.
    Thompson DM; Meloche M; Ao Z; Paty B; Keown P; Shapiro RJ; Ho S; Worsley D; Fung M; Meneilly G; Begg I; Al Mehthel M; Kondi J; Harris C; Fensom B; Kozak SE; Tong SO; Trinh M; Warnock GL
    Transplantation; 2011 Feb; 91(3):373-8. PubMed ID: 21258272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Continuous Subcutaneous Insulin Infusion Therapy on Efficacy and Safety in a Cohort of Type 1 Diabetes Patients: A 3-Year Prospective Study.
    Melidonis A; Kamaratos A; Angelidi A; Thomakos P; Vrakas S; Bakalis J; Fousteris E; Iraklianou S
    Diabetes Technol Ther; 2016 Mar; 18(3):159-63. PubMed ID: 26862678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.